tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

FDMT Stock Latest News

Buy Rating Affirmed for 4D-150: Promising Phase 2a SPECTRA Trial Results and Market Potential
RatingsBuy Rating Affirmed for 4D-150: Promising Phase 2a SPECTRA Trial Results and Market Potential
5d ago
FDMT
4D Molecular Therapeutics Faces Revenue Challenges Amid Complex Reimbursement Landscape
PremiumCompany Announcements
4D Molecular Therapeutics Faces Revenue Challenges Amid Complex Reimbursement Landscape
5d ago
FDMT
4D Molecular Therapeutics Advances Clinical Programs in Q2 2025
PremiumCompany Announcements
4D Molecular Therapeutics Advances Clinical Programs in Q2 2025
5d ago
FDMT
4D Molecular price target lowered to $16 from $17 at Leerink
PremiumThe Fly
4D Molecular price target lowered to $16 from $17 at Leerink
6d ago
FDMT
Morning Movers: MeridianLink jumps after pact to be acquired by Centerbridge
PremiumThe Fly
Morning Movers: MeridianLink jumps after pact to be acquired by Centerbridge
6d ago
B
EE
4D Molecular reports 2Q EPS (98c) vs (63c) last year
PremiumThe Fly4D Molecular reports 2Q EPS (98c) vs (63c) last year
6d ago
FDMT
Promising Phase 2 Trial Results and Strategic Developments Support Buy Rating for 4D Molecular Therapeutics
Premium
Ratings
Promising Phase 2 Trial Results and Strategic Developments Support Buy Rating for 4D Molecular Therapeutics
13d ago
FDMT
Promising Potential of 4D-150 in DME and wAMD: Buy Rating Affirmed by Analyst
Premium
Ratings
Promising Potential of 4D-150 in DME and wAMD: Buy Rating Affirmed by Analyst
16d ago
FDMT
Promising Phase 2a SPECTRA Trial Results and Strategic Focus Drive Buy Rating for 4D-150 in Diabetic Macular Edema
PremiumRatings
Promising Phase 2a SPECTRA Trial Results and Strategic Focus Drive Buy Rating for 4D-150 in Diabetic Macular Edema
16d ago
FDMT
4D Molecular presents SPECTRA data at ASRS meeting
PremiumThe Fly
4D Molecular presents SPECTRA data at ASRS meeting
17d ago
FDMT
Bullish Outlook on 4D Molecular Therapeutics’ 4D-150: Promising Clinical Data and Market Potential in Diabetic Macular Edema Treatment
PremiumRatings
Bullish Outlook on 4D Molecular Therapeutics’ 4D-150: Promising Clinical Data and Market Potential in Diabetic Macular Edema Treatment
19d ago
FDMT
4D Molecular Therapeutics’ Phase 3 Trial: A New Hope for Age-Related Macular Degeneration?
PremiumCompany Announcements
4D Molecular Therapeutics’ Phase 3 Trial: A New Hope for Age-Related Macular Degeneration?
1M ago
FDMT
Optimistic Buy Rating for 4D Molecular Therapeutics Amid Strategic Advancements and Market Interest
PremiumRatingsOptimistic Buy Rating for 4D Molecular Therapeutics Amid Strategic Advancements and Market Interest
1M ago
FDMT
Closing Bell Movers: Datadog jumps 11% on S&P 500 inclusion
Premium
The Fly
Closing Bell Movers: Datadog jumps 11% on S&P 500 inclusion
2M ago
FC
APP
4D Molecular Therapeutics Updates Phase 3 Program for Wet AMD
Premium
Company Announcements
4D Molecular Therapeutics Updates Phase 3 Program for Wet AMD
2M ago
8K
FDMT
4D Molecular reduces workforce by 25%, announces accelerated 4FRONT-2 trial
PremiumThe Fly
4D Molecular reduces workforce by 25%, announces accelerated 4FRONT-2 trial
2M ago
FDMT
4D Molecular Therapeutics Holds Annual Stockholders Meeting
PremiumCompany Announcements
4D Molecular Therapeutics Holds Annual Stockholders Meeting
2M ago
8K
FDMT
Promising Potential and Financial Stability Drive Buy Rating for 4D Molecular Therapeutics
PremiumRatings
Promising Potential and Financial Stability Drive Buy Rating for 4D Molecular Therapeutics
3M ago
FDMT
Promising Advancements in 4D Molecular Therapeutics’ Gene Therapy Programs Drive Buy Rating
PremiumRatings
Promising Advancements in 4D Molecular Therapeutics’ Gene Therapy Programs Drive Buy Rating
3M ago
FDMT
4D Molecular price target lowered to $38 from $45 at Barclays
PremiumThe Fly4D Molecular price target lowered to $38 from $45 at Barclays
3M ago
FDMT
4D Molecular Therapeutics Reports Increased Quarterly Loss
Premium
Company Announcements
4D Molecular Therapeutics Reports Increased Quarterly Loss
3M ago
FDMT
4D Molecular reports Q1 EPS (86c), consensus (86c)
Premium
The Fly
4D Molecular reports Q1 EPS (86c), consensus (86c)
3M ago
FDMT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >